Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
22:07:43 EDT Fri 19 Apr 2024
Enter Symbol
or Name
USA
CA



News for U:ENDP from 2023-04-20 to 2024-04-19 - 53 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-03-26 07:30U:ENDPNews ReleaseEndo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS(TM)
2024-03-26 07:30U:ENDPNews ReleaseEndo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS(TM)
2024-03-19 17:30U:ENDPNews ReleaseEndo Announces Confirmation of Plan of Reorganization
2024-03-19 17:30U:ENDPNews ReleaseEndo Announces Confirmation of Plan of Reorganization
2024-03-12 14:00U:ENDPNews ReleasePar Pharmaceutical Issues Voluntary Nationwide Recall of One Lot of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution
2024-03-06 19:41U:ENDPSEDAR MD & ASEDAR MD & A
2024-03-06 19:18U:ENDPSEDAR Annual ReportSEDAR Annual Report
2024-03-06 16:15U:ENDPNews ReleaseENDO REPORTS FOURTH-QUARTER 2023 FINANCIAL RESULTS
2024-03-06 16:15U:ENDPNews ReleaseENDO REPORTS FOURTH-QUARTER 2023 FINANCIAL RESULTS
2024-02-29 11:43U:ENDPNews ReleaseEndo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana(TM) ER
2024-02-29 11:43U:ENDPNews ReleaseEndo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana(TM) ER
2024-01-24 07:30U:ENDPNews ReleaseEndo Announces Publication of New XIAFLEX ® (collagenase clostridium histolyticum) Survey Data in Journal of Hand Surgery Global Open
2024-01-24 07:30U:ENDPNews ReleaseEndo Announces Publication of New XIAFLEX ‚ ® (collagenase clostridium histolyticum) Survey Data in Journal of Hand Surgery Global Open
2023-11-30 07:30U:ENDPNews ReleaseEndo Launches Unscripted Video Series With Real Peyronie's Disease Patients
2023-11-30 07:30U:ENDPNews ReleaseEndo Launches Unscripted Video Series With Real Peyronie's Disease Patients
2023-11-16 07:30U:ENDPNews ReleaseEndo Announces Five Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting
2023-11-16 07:30U:ENDPNews ReleaseEndo Announces Five Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting
2023-11-06 18:13U:ENDPSEDAR Interim MD & ASEDAR Interim MD & A
2023-11-06 17:58U:ENDPSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-06 16:05U:ENDPNews ReleaseENDO REPORTS THIRD-QUARTER 2023 FINANCIAL RESULTS
2023-11-06 16:05U:ENDPNews ReleaseENDO REPORTS THIRD-QUARTER 2023 FINANCIAL RESULTS
2023-09-21 07:45U:ENDPNews ReleaseEndo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting
2023-09-21 07:45U:ENDPNews ReleaseEndo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting
2023-08-08 13:13U:ENDPSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-08 07:45U:ENDPNews ReleaseENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS
2023-08-08 07:45U:ENDPNews ReleaseENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS
2023-07-20 07:30U:ENDPNews ReleaseEndo Announces First Patient Enrolled in Registry of Peyronie's Disease
2023-07-20 07:30U:ENDPNews ReleaseEndo Announces First Patient Enrolled in Registry of Peyronie's Disease
2023-07-18 16:30U:ENDPNews ReleaseEndo Launches Bivalirudin Injection in Ready-to-Use Vials
2023-07-18 16:30U:ENDPNews ReleaseEndo Launches Bivalirudin Injection in Ready-to-Use Vials
2023-07-17 16:30U:ENDPNews ReleaseEndo and Premier, Inc. Collaborate to Address Pitocin ® (oxytocin injection, USP) Shortage
2023-07-17 16:30U:ENDPNews ReleaseEndo and Premier, Inc. Collaborate to Address Pitocin ‚ ® (oxytocin injection, USP) Shortage
2023-07-13 16:30U:ENDPNews ReleaseEndo Presents New Data at the American Podiatric Medical Association Annual Meeting
2023-07-13 16:30U:ENDPNews ReleaseEndo Presents New Data at the American Podiatric Medical Association Annual Meeting
2023-06-29 16:30U:ENDPNews ReleaseEndo Launches First Generic Version of Noxafil ® (posaconazole) Injection
2023-06-29 16:30U:ENDPNews ReleaseEndo Launches First Generic Version of Noxafil ‚ ® (posaconazole) Injection
2023-06-29 07:30U:ENDPNews ReleaseEndo Announces Approval of XCOPRI ™ (cenobamate tablets) in Canada
2023-06-29 07:30U:ENDPNews ReleaseEndo Announces Approval of XCOPRI ¢ „ ¢ (cenobamate tablets) in Canada
2023-06-26 07:30U:ENDPNews ReleaseEndo Announces First Patient Enrolled in Registry of Dupuytren's Contracture
2023-06-26 07:30U:ENDPNews ReleaseEndo Announces First Patient Enrolled in Registry of Dupuytren's Contracture
2023-06-15 07:30U:ENDPNews ReleaseEndo Launches Dexlansoprazole Capsules, Generic Version of Dexilant ®
2023-06-15 07:30U:ENDPNews ReleaseEndo Launches Dexlansoprazole Capsules, Generic Version of Dexilant ‚ ®
2023-06-12 07:30U:ENDPNews ReleaseEndo Launches PREVDUO ™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe
2023-06-12 07:30U:ENDPNews ReleaseEndo Launches PREVDUO ¢ „ ¢ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe
2023-06-05 07:30U:ENDPNews ReleaseEndo Announces Publication of XIAFLEX ® (collagenase clostridium histolyticum) Data Analysis in Peer-Reviewed Urology ®
2023-06-05 07:30U:ENDPNews ReleaseEndo Announces Publication of XIAFLEX ‚ ® (collagenase clostridium histolyticum) Data Analysis in Peer-Reviewed Urology ‚ ®
2023-05-24 07:30U:ENDPNews ReleaseEndo Announces Agreement with MAIA Pharmaceuticals to Distribute Bivalirudin Injection in Ready-to-Use Vials
2023-05-24 07:30U:ENDPNews ReleaseEndo Announces Agreement with MAIA Pharmaceuticals to Distribute Bivalirudin Injection in Ready-to-Use Vials
2023-05-08 13:36U:ENDPSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-05-08 07:30U:ENDPNews ReleaseENDO REPORTS FIRST-QUARTER 2023 FINANCIAL RESULTS
2023-05-08 07:30U:ENDPNews ReleaseENDO REPORTS FIRST-QUARTER 2023 FINANCIAL RESULTS
2023-04-26 07:30U:ENDPNews ReleaseEndo Announces Agreement with Slayback Pharma to Distribute Prevduo ™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Product in the U.S.
2023-04-26 07:30U:ENDPNews ReleaseEndo Announces Agreement with Slayback Pharma to Distribute Prevduo ¢ „ ¢ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Product in the U.S.